News

Published on 1 Mar 2024 on Simply Wall St. via Yahoo Finance

Arvinas, Inc. (NASDAQ:ARVN) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The ...


Article preview image

It's shaping up to be a tough period for Arvinas, Inc. (NASDAQ:ARVN), which a week ago released some disappointing full-year results that could have a notable impact on how the market views the stock. It was not a great statutory result, with revenues coming in 54% lower than the analysts predicted. Unsurprisingly, earnings also fell seriously short of forecasts, turning into a per-share loss of US$6.62. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Arvinas after the latest results.

See our latest analysis for Arvinas

earnings-and-revenue-growthearnings-and-revenue-growth

NASDAQ.ARVN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Arvinas, Inc. (ARVN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Arvinas, Inc. (ARVN) is expected to deliver a year-over-year increase in earnings on higher reven...

Zacks via Yahoo Finance 26 Apr 2024

Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate

Novartis NVS entered into an exclusive strategic license agreement with a clinical-stage biotechn...

Zacks via Yahoo Finance 12 Apr 2024

H.C. Wainwright lowers Arvinas shares target amid Novartis licensing deal for ARV-766

H.C. Wainwright lowers Arvinas shares target amid Novartis licensing deal for ARV-766

Investing.com 11 Apr 2024

Stifel lifts Arvinas shares PT on ARV-766 sales forecast update By Investing.com

On Thursday, Stifel maintained a Buy rating on Arvinas Inc. (NASDAQ:ARVN) and increased the price...

Investing.com 11 Apr 2024

Arvinas inks over $1.0 billion deal with Novartis

Arvinas Inc (NASDAQ: ARVN) is in the green at writing after announcing a deal worth over $1.0 bil...

Invezz 11 Apr 2024

Is Arvinas (ARVN) Stock a Solid Choice Right Now?

One stock that might be an intriguing choice for investors right now is Arvinas, Inc. ARVN. This ...

Zacks via Yahoo Finance 9 Apr 2024

Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving...

U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday. Shares of The ...

Benzinga 1 Mar 2024

Arvinas, Inc. (NASDAQ:ARVN) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The ...

It's shaping up to be a tough period for Arvinas, Inc. (NASDAQ:ARVN), which a week ago released s...

Simply Wall St. via Yahoo Finance 1 Mar 2024

Is a Surprise Coming for Arvinas (ARVN) This Earnings Season?

Investors are always looking for stocks that are poised to beat at earnings season and Arvinas, I...

Zacks via Yahoo Finance 28 Feb 2024

Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates

Arvinas, Inc. (ARVN) came out with a quarterly loss of $2.53 per share versus the Zacks Consensus...

Zacks via Yahoo Finance 27 Feb 2024